Assessing the potential of glucokinase activators in diabetes therapy (original) (raw)

• Matschinsky, F. M. et al. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55, 1–12 (2006).
  CAS PubMed Google Scholar
• Grimsby, J. et al. Allosteric activation of islet and hepatic glucokinase: a potential new approach to diabetes therapy. Diabetes Abstr. 50 (Suppl. 2), A115 (2001).
  Google Scholar
• Doliba, N. et al. Novel pharmacological glucokinase activators enhance glucose metabolism, respiration and insulin release in isolated pancreatic islets demonstrating a unique therapeutic potential (Abstr. 1495-P; 61st ADA Meeting, Philadelphia). Diabetes 50 (Suppl. 2), A359 (2001).
  Google Scholar
• Cuesta-Munoz, A. L. et al. Novel pharmacological glucokinase activators partly or fully reverse the catalytic defects of inactivating glucokinase missense mutants that cause MODY-2. Diabetes Abstr. 50 (Suppl. 2), A109 (2001).
  Google Scholar
• Grimsby, J. et al. Allosteric activators of glucokinase: potential role in diabetes therapy. Science 301, 370–373 (2003). First peer-reviewed report on the discovery and potential of GKAs.
  CAS PubMed Google Scholar
• Grimsby, J., Matschinsky, F. M. & Grippo J. F . in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. Vol. 16. (eds Matschinsky, F. M. & Magnuson, M. A.) 360–378 (Karger, Basel, 2004).
  Google Scholar
• Meglasson, M. D. & Matschinsky, F. M. in Diabetes/Metabolism Reviews 3: Regulation of Insulin Secretion (ed. DeFronzo, R. A.) 163–214 (John Wiley & Sons, New York, 1986).
  Google Scholar
• Matschinsky, F. M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45, 223–241 (1996).
  CAS PubMed Google Scholar
• Walker, D. G. & Rao, S. The role of glucokinase in the phosphorylation of glucose by rat liver. Biochem. J. 90, 360–368 (1964). First peer-reviewed report on the presence and significance of hepatic glucokinase.
  CAS PubMed PubMed Central Google Scholar
• Sols, A., Salas, M. & Vinuela, E. Induced biosynthesis of liver glucokinase. Adv. Enzyme Regul. 2, 177–188 (1964).
  CAS PubMed Google Scholar
• Sharma, C., Manjeshwar, R. & Weinhouse, S. Hormonal and dietary regulation of hepatic glucokinase. Adv. Enzyme Regul. 2, 189–200 (1964).
  CAS PubMed Google Scholar
• Matschinsky, F. M. & Ellerman, J. E. Metabolism of glucose in the islets of Langerhans. J. Biol. Chem. 243, 2730–2736 (1968). First report on the presence and significance of glucokinase in mouse pancreatic islets.
  CAS PubMed Google Scholar
• Bedoya, F. J., Matschinsky, F. M., Shimizu, T., O'Neil, J. J. & Appel, M. C. Differential regulation of glucokinase activity in pancreatic islets and liver of the rat. J. Biol. Chem. 261, 10760–10764 (1986). First report providing evidence for differential control of glucokinase expression, primarily by glucose in pancreatic islet tissue and by insulin in the liver.
  CAS PubMed Google Scholar
• Froguel, P. et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356, 162–164 (1992).
  CAS PubMed Google Scholar
• Hattersley, A. T. et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 339, 1307–1310 (1992).
  CAS PubMed Google Scholar
• Edghill, E. L. & Hattersley, A. T. in Pancreatic Beta Cell in Health and Disease (eds Seino, S. & Bell, G. I.) 399–430 (Springer, Tokyo2008). Authoritative review of glucokinase-linked hyperglycaemia syndromes.
  Google Scholar
• Glaser, B. et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N. Engl. J. Med. 338, 226–230 (1998). First report on glucokinase-linked hyperinsulinism syndrome.
  CAS PubMed Google Scholar
• Christesen, H. et al. The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes 51, 1240–1246 (2002).
  CAS PubMed Google Scholar
• Gloyn, A. L. et al. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 52, 2433–2440 (2003).
  CAS PubMed Google Scholar
• MCuesta-uñoz, A. L. et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 53, 2164–2168 (2004).
  Google Scholar
• Njolstad, P. R. et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N. Engl. J. Med. 344, 1588–1592 (2001).
  CAS PubMed Google Scholar
• Njølstad, P. R. et al. Permanent neonatal diabetes mellitus due to glucokinase deficiency — an inborn error of the glucose–insulin signaling pathway. Diabetes 52, 2854–2860 (2003).
  PubMed Google Scholar
• Brocklehurst, K. J. et al. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes 53, 535–541 (2004).
  CAS PubMed Google Scholar
• Kamata, K., Mitsuya, M., Nishimura, T., Eiki, J. & Nagata, Y. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure (Camb.) 12, 429–438 (2004). Seminal report on the crystal structures of the unliganded 'super-open' form and the glucose- and GKA-containing ternary complex of the 'closed-form' of glucokinase; also provides a plausible model explaining the cooperative kinetics of glucokinase with regard to glucose.
  CAS Google Scholar
• Dunten, P. et al. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 145–154 (Karger, Basel, 2004).
  Google Scholar
• Futamura, M. et al. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism. J. Biol. Chem. 281, 37668–37674 (2006).
  CAS PubMed Google Scholar
• Efanov, A. M. et al. A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 146, 3696–3701 (2005).
  CAS PubMed Google Scholar
• Fyfe, M. C. T. et al. Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions. Diabetologia 50, 1277–1287 (2007).
  CAS PubMed Google Scholar
• Leighton, B., Atkinson, A., Coope, G. J. & Coghlan, M. P. Improved glycemic control after sub-acute administration of a glucokinase activator to male Zucker (fa/fa) rats. Diabetes Abstr. 56, 0377–OR (2007).
  Google Scholar
• Sorhede Winzell, M. et al. Glucokinase activation reduces glycemia and improves glucose tolerance in mice with high-fat diet-induced insulin resistance. Diabetes Abstr. 56, 1482—P (2007).
  Google Scholar
• Nakamura, A. et al. Impact of small molecule glucokinase activator on glucose metabolism in response to high fat diet in mice with β-cell specific haploinsufficiency of glucokinase gene. Diabetes Abstr. 56, 529–P (2007).
  Google Scholar
• Coghlan, M. & Leighton, B. Glucokinase activators in diabetes management. Expert Opin. Investig. Drugs 17, 145–167 (2008).
  CAS PubMed Google Scholar
• Guertin, K. R & Grimsby, J. Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy. Curr. Med. Chem. 13, 1839–1843 (2006).
  CAS PubMed Google Scholar
• Sarabu, R., Berthel, S. J., Kester, R. F. & Tilley, J. W. Glucokinase activators as new type 2 diabetes therapeutic agents. Expert Opin. Ther. Patents 18, 759–768 (2008).
  CAS Google Scholar
• Sarabu, R. & Grimsby, J. Targeting glucokinase activation for the treatment of type 2 diabetes — a status review. Curr. Opin. Drug Discov. Devel. 8, 631–637 (2005).
  CAS PubMed Google Scholar
• Cárdenas, M. L., Cornish-Bowden, A. & Ureta, T. Evolution and regulatory role of the hexokinases. Biochim. Biophys. Acta 1401, 242–264 (1998).
  PubMed Google Scholar
• Wilson, J. E. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 18–30 (Karger, Basel, 2004).
  Google Scholar
• Iynedjian, P. B. Mammalian glucokinase and its gene. Biochem. J. 293, 1–13 (1993).
  CAS PubMed PubMed Central Google Scholar
• Iynedjian, P. B. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 155–168 (Karger, Basel, 2004).
  Google Scholar
• Postic, C., Shiota, M. & Magnuson, M. A. Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog. Horm. Res. 56, 195–218 (2001).
  CAS PubMed Google Scholar
• Iynedjian, P. B. Molecular physiology of mammalian glucokinase. Cell. Mol. Life Sci. 66, 27–42 (2008).
  PubMed Central Google Scholar
• Vandercammen, A. & Van Schaftingen, E. The mechanism by which rat liver glucokinase is inhibited by the regulatory protein. Eur. J. Biochem. 191, 483–489 (1990). Original report describing the discovery of the glucokinase regulatory protein in liver tissue.
  CAS PubMed Google Scholar
• Vandercammen, A. & Van Schaftingen, E. Competitive inhibition of liver glucokinase by its regulatory protein. Eur. J. Biochem. 200, 545–551 (1991).
  CAS PubMed Google Scholar
• Detheux, M., Vandercammen, A. & Van Schaftingen, E. Effectors of the regulatory protein acting on liver glucokinase: a kinetic investigation. Eur. J. Biochem. 200, 553–561 (1991).
  CAS PubMed Google Scholar
• Veiga-da-Cunha, M. & Van Schaftingen, E. Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase. J. Biol. Chem. 277, 8466–8473 (2002).
  CAS PubMed Google Scholar
• Agius, L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem. J. 414, 1–18 (2008).
  CAS PubMed Google Scholar
• Agius, L. & Peak, M. Intracellular binding of glucokinase in hepatocytes and translocation by glucose, fructose and insulin. Biochem. J. 296, 785–796 (1993).
  CAS PubMed PubMed Central Google Scholar
• Agius, L., Peak, M. & Van Schaftingen, E. The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation. Biochem. J. 309, 711–713 (1995).
  CAS PubMed PubMed Central Google Scholar
• Agius, L. The physiological role of glucokinase binding and translocation in hepatocytes. Adv. Enzyme Regul. 38, 303–331 (1998).
  CAS PubMed Google Scholar
• Payne, V. A., Arden, C., Lange, A. J. & Agius, L. Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R618–R625 (2007).
  CAS PubMed Google Scholar
• Baltrusch, S., Wu, C., Okar, D. A., Tiedge, M. & Lange, A. J. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 262–274 (Karger, Basel, 2004).
  Google Scholar
• Danial, N. N. et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424, 952–956 (2003).
  CAS PubMed Google Scholar
• Danial, N. N. et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nature Med. 14, 144–153 (2008). Report on the presence and dual role of the pro-apoptotic protein BAD in pancreatic islet tissue — that is, as regulator of β-cell replication and as a protein-binding partner of mitochondrial glucokinase, controlling glucose-stimulated insulin release.
  CAS PubMed Google Scholar
• Heredia, V. V., Thomson, J., Nettleton, D. & Sun, S. Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis. Biochemistry 45, 7553–7562 (2006).
  CAS PubMed Google Scholar
• Kim, Y. B., Kalinowski, S. S. & Marcinkeviciene, J. A pre-steady state analysis of ligand binding to human glucokinase: evidence for a preexisting equilibrium. Biochemistry 46, 1423–1431 (2007).
  CAS PubMed Google Scholar
• Zhang, J. et al. Conformational transition pathway in the allosteric process of human glucokinase. Proc. Natl Acad. Sci. USA 103, 13368–13373 (2006).
  CAS PubMed Google Scholar
• Zelent, B. et al. Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence. Biochem J. 413, 269–280 (2008).
  CAS PubMed Google Scholar
• Lin, S. X. & Neet, K. E. Demonstration of a slow conformational change in liver glucokinase by fluorescence spectroscopy. J. Biol. Chem. 265, 9670–9675 (1990). Authoritative discussion of the 'slow transition model', which explains the sigmoidal glucose dependency of the glucokinase reaction.
  CAS PubMed Google Scholar
• Neet, K. E. & Ainslie, G. R. Hysteretic enzymes. Methods Enzymol. 64, 192–226 (1980).
  CAS PubMed Google Scholar
• Cornish-Bowden, A. & Cárdenas, M. L. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. Vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 125–134 (Karger, Basel, 2004). Brief expert discussion of the 'mnemonic model' explaining the sigmoidal glucose dependency of the glucokinase reaction.
• Jetton, T. L. et al. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269, 3641–3654 (1994).
  CAS PubMed Google Scholar
• Zelent, D. et al. A glucose sensor role for glucokinase in anterior pituitary cells. Diabetes 55, 1923–1929 (2006).
  CAS PubMed Google Scholar
• Sorenson, R. L., Stout, L. E., Brelje, T. C., Jetton, T. & Matschinsky, F. M. Immunohistochemical evidence for the presence of glucokinase in the gonadotropes and thyrothropes of the anterior pituitary gland of rat and monkey. J. Histochem. Cytochem. 55, 555–566 (2007). First report on the presence and possible role of glucokinase in gonadotropes of the pituitary gland.
  CAS PubMed Google Scholar
• Zelent, D. et al. Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem. Soc. Trans. 33, 306–310 (2005).
  CAS PubMed Google Scholar
• Leibiger, B. et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol. Cell 7, 559–570 (2001).
  CAS PubMed Google Scholar
• Levin, B. E., Routh, V. H., Kang, L., Sanders, N. M. & Dunn-Meynell, A. A. Neuronal glucosensing: what do we know after 50 years? Diabetes 53, 2521–2528 (2004).
  CAS PubMed Google Scholar
• Levin, B. E., Becker, T. C., Eiki, J.-I., Zhang, B. B. & Dunn-Meynell, A. A. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes 57, 1371–1379 (2008).
  CAS PubMed Google Scholar
• Mountjoy, P. D. & Rutter, G. A. Glucose sensing by hypothalamic neurones and pancreatic islet cells: AMPle evidence for common mechanisms? Exp. Physiol. 92, 311–319 (2007).
  CAS PubMed Google Scholar
• Thorens, B. The Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. Vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 327–338 (Karger, Basel, 2004).
  Google Scholar
• Donovan, C. M., Hamilton-Wessler, M., Halter, J. B. & Bergman, R. N. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc. Natl Acad. Sci. USA 91, 2863–2867 (1994).
  CAS PubMed Google Scholar
• Cherrington, A. D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48, 1198–1214 (1999). Authoritative discussion of the regulation of hepatic glucose metabolism, including evaluation of mechanisms underlying the 'portal signal'.
  CAS PubMed Google Scholar
• Trus, M. D. et al. Regulation of glucose metabolism in pancreatic islets. Diabetes 30, 911–922 (1981).
  CAS PubMed Google Scholar
• Bedoya, F. D., Wilson, J. M., Ghosh, A. K., Finegold, D. & Matschinsky, F. M. The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes 35, 61–67 (1986). First report on quantitative measurements and significance of glucokinase in normal human pancreatic islet tissue.
  CAS PubMed Google Scholar
• Liang, Y., Najafi, H. & Matschinsky, F. M. Glucose regulates glucokinase activity in cultured islets from rat pancreas. J. Biol. Chem. 265, 16863–16866 (1990).
  CAS PubMed Google Scholar
• Liang, Y. Concordant glucose induction of glucokinase, glucose usage and glucose stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes 41, 792–806 (1992).
  CAS PubMed Google Scholar
• Tal, M., Liang, Y., Najafi, H., Lodish, H. F. & Matschinsky, F. M. Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets. J. Biol. Chem. 267, 17241–17247 (1992).
  CAS PubMed Google Scholar
• Newgard, C. B. & Matschinsky, F. M. in The Endocrine System Vol. II: The Endocrine Pancreas and Regulation of Metabolism. Handbook of Physiology. 125–151 (Oxford Univ. Press, Oxford 2001).
  Google Scholar
• MacDonald, M. J. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. J. Biol. Chem. 270, 20051–20058 (1995).
  CAS PubMed Google Scholar
• Li, C. et al. Elimination of KATP channels in mouse islets results in elevated [U-13C]glucose metabolism, glutaminolysis, and pyruvate cycling but a decreased γ-aminobutyric acid shunt. J. Biol. Chem. 283, 17238–17249 (2008).
  CAS PubMed PubMed Central Google Scholar
• Henquin, J. C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49, 1751–1760 (2000).
  CAS PubMed Google Scholar
• Prentki, M. & Matschinsky, F. M. Ca2+, cAMP and phosphoinositide derived messengers in the coupling mechanisms of insulin secretion. Physiol. Rev. 67, 1185–1248 (1987).
  CAS PubMed Google Scholar
• Hardie, D. G. & Carling, D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259–273 (1997).
  CAS PubMed Google Scholar
• Trus, M. D et al. A comparison of the effects of glucose and acetylcholine on insulin release and intermediary metabolism in rat pancreatic islets. J. Biol. Chem. 254, 3921–3929 (1979).
  CAS PubMed Google Scholar
• Trus, M., Warner, H. & Matschinsky, F. M. Effects of glucose on insulin release and on intermediary metabolism of isolated perifused pancreatic islets from fed and fasted rats. Diabetes 29, 1–14 (1980).
  CAS PubMed Google Scholar
• Gromada, J., Franklin, I. & Wollheim, C. B. α-Cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr. Rev. 28, 84–116 (2007).
  CAS PubMed Google Scholar
• Liu, Y.-J., Vieira, E. & Gylfe, E. A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting α-cell. Cell Calcium 35, 357–365 (2004).
  CAS PubMed Google Scholar
• Vieira, E., Salehi, A. & Gylfe, E. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells. Diabetologia, 50, 370–379 (2007).
  CAS PubMed Google Scholar
• Pagliara, A. S., Stillings, S. N., Hover, B., Martin, D. M. & Matschinsky, F. M. Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas. J. Clin. Invest. 54, 819–832 (1974).
  CAS PubMed PubMed Central Google Scholar
• Pagliara, A. S., Stillings, S. N., Haymond, M. W., Hover, B. A. & Matschinsky, F. M. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats. J. Clin. Invest. 55, 244–255 (1975).
  CAS PubMed PubMed Central Google Scholar
• Matschinsky, F. M., Pagliara, A. S., Stillings, S. N. & Hover, B. A. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats. J. Clin. Invest. 58, 1193–1200 (1976).
  CAS PubMed PubMed Central Google Scholar
• Matschinsky, F. M. et al. Hormone secretion and glucose metabolism in islets of Langerhans of the isolated perfused pancreas from normal and streptozotocin diabetic rats. J. Biol. Chem. 251, 6053–6061 (1976).
  CAS PubMed Google Scholar
• Pagliara, A. S., Stillings, S. N., Zawalich, W. S., Williams, A. D. & Matchinsky, F. M. Glucose and 3-_O_-methylglucose protection against alloxan poisoning of pancreatic alpha and beta cells. Diabetes 26, 973–979 (1977).
  CAS PubMed Google Scholar
• Matschinsky, F. M., Rujanavech, C., Pagliara, A. & Norfleet, W. T. Adaptations of alpha2- and beta-cells of rat and mouse pancreatic islets to starvation, to refeeding after starvation, and to obesity. J. Clin. Invest. 65, 207–218 (1980).
  CAS PubMed PubMed Central Google Scholar
• Reimann, F., Ward, P. S. & Gribble, F. M. Signalling mechanisms underlying the release of glucagon-like peptide-1. Diabetes 55 (Suppl. 2), S78–S85 (2006).
  CAS Google Scholar
• Reimann, F., Williams, L., da Silva Xavier, G., Rutter, G. A. & Gribble, F. M. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 47, 1592–1601 (2004).
  CAS PubMed Google Scholar
• Reimann, F. et al. Glucose sensing in L cells: a primary cell study. Cell Metab. 8, 532–539 (2008).
  CAS PubMed PubMed Central Google Scholar
• Murphy, R. et al. Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor. Diabetologia 52, 154–159 (2008).
  PubMed Google Scholar
• Matschinsky, F. M. in Pancreatic Beta Cell in Health and Disease (eds Seino, S. & Bell, G. I.) 451–463 (Springer, Tokyo, 2008).
  Google Scholar
• Hille, B., Tse, A. Tse, F. W. & Bosma, M. M. Signaling mechanisms during the response of pituitary gonadotropes to GnRH. Recent Prog. Horm. Res. 50, 75–95 (1995).
  CAS PubMed Google Scholar
• Torres, T. P. et al. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in Zucker diabetic fatty rats. Diabetes 24 Oct 2008 (doi:10.2337/db08-1119)
  PubMed Google Scholar
• Nelson, D. L. & Cox, M. M. (eds) Lehninger Principles of Biochemistry 569–613 (W. H. Freeman, New York, 2008).
  Google Scholar
• Nelson, D. L. & Cox, M. M. (eds) Lehninger Principles of Biochemistry 901–944 (W. H. Freeman, New York, 2008).
  Google Scholar
• Magnuson, M. A. & Kim, K.-A. Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes Vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 289–300 (Karger, Basel, 2004).
  Google Scholar
• Gloyn, A. L. et al. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes Vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 92–109 (Karger, Basel, 2004).
  Google Scholar
• Pino, M. F. Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations. J. Biol. Chem. 282, 13906–13916 (2007).
  CAS PubMed Google Scholar
• LeRoith, D., Taylor, S. I., & Olefsky, J. M. (eds) Diabetes Mellitus: A Fundamental and Clinical Text. 3rd edn (Lippincott Williams & Wilkins, Philadelphia, 2004).
  Google Scholar
• McCarthy, M. I. & Froguel, P. Genetic approaches to the molecular understanding of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 283, E217–E225 (2002).
  CAS PubMed Google Scholar
• Chen, W. M. et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J. Clin. Invest. 118, 2620–2628 (2008).
  CAS PubMed PubMed Central Google Scholar
• Wilms, B., Ben-Ami, P. & Söling, H. D. Hepatic enzyme activities of glycolysis and gluconeogenesis in diabetes of man and laboratory animals. Horm. Metab. Res. 2, 135–141 (1970).
  Google Scholar
• Caro, J. F. et al. Liver glucokinase: decreased activity in patients with type II diabetes. Horm. Metab. Res. 27, 19–22 (1995).
  CAS PubMed Google Scholar
• Liang, Y. et al. In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents. J. Clin. Invest. 93, 2473–2481 (1994).
  CAS PubMed PubMed Central Google Scholar
• Bedoya, F. J., Oberholtzer, J. C. & Matschinsky, F. M. Glucokinase in B-cell-depleted islets of Langerhans. J. Histochem. Cytochem. 35, 1089–1093 (1987).
  CAS PubMed Google Scholar
• Deng, S. et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53, 624–632 (2004).
  CAS PubMed Google Scholar
• Nolte, M. S. & Karam, J. H. in Basic and Clinical Pharmacology 10th edn (ed. Katzung, B. G.) 683–705 (McGraw-Hill, New York, 2007).
  Google Scholar
• Qian-Cutrone, J. et al. Glucolipsin A and B, two new glucokinase activators produced by Streptomyces purpurogeniscleroticus and Nocardia vaccinii. J. Antibiot. (Tokyo) 52, 245–255 (1999).
  CAS Google Scholar
• Gloyn, A. L. et al. Insights into the structure and regulation of glucokinase from a novel mutation (V62M) which causes maturity-onset diabetes of the young. J. Biol. Chem. 280, 14105–14113 (2005).
  CAS PubMed Google Scholar
• Sagen, J. V. et al. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes 55, 1713–1722 (2006).
  CAS PubMed Google Scholar
• Ralph, E. C., Thomson, J., Almaden, J. & Sun, S. Glucose modulation of glucokinase activation by small molecules. Biochemistry 47, 5028–5036 (2008).
  CAS PubMed Google Scholar
• Johnson, D. et al. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. Diabetes 56, 1694–1702 (2007).
  CAS PubMed Google Scholar
• Zhi, J. et al. A novel glucokinase activator RO4389620 improved fasting and postprandial plasma glucose in type 2 diabetic patients. Diabetologia 51 (Suppl. 1), 23 Abstr. 42 (2008).
• Bonadonna, R. C. et al. Glucokinase activator RO4389620 improves beta cell function and plasma glucose indexes in patients with type 2 diabetes. Diabetologia 51 (Suppl. 1), 371 Abstr. 927 (2008). Abstract describing improvement of β-cell function by GKAs in patients with T2DM.
• Zhai, S. et al. Phase I assessment of a novel glucose activator RO4389620 in healthy male volunteers. Diabetologia 51 (Suppl. 1) 372 Abstr. 928 (2008).
• Coope, G. J. et al. Predictive blood glucose lowering efficacy by glucokinase activators in high fat fed female Zucker rats. Brit. J. Pharmacol. 149, 328–335 (2006).
  CAS Google Scholar
• Vaxillaire, M. et al. for the DESIR Study Group. The common P446L polymorphism in GCAR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57, 2253–2257 (2008).
  CAS PubMed PubMed Central Google Scholar
• Orho-Melander, M. et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57, 3112–3121 (2008).
  CAS PubMed PubMed Central Google Scholar
• Sparsø, T. et al. Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation. Diabetologia 51, 70–75 (2008).
  PubMed Google Scholar
• Terauchi, Y. et al. Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest. 117, 246–257 (2007). Report of studies that strongly suggest that glucokinase and insulin-receptor substrate-2 are required for compensatory β-cell hyperplasia in diet-induced obesity and diabetes.
  CAS PubMed PubMed Central Google Scholar
• Takamoto, I. et al. Crucial role of insulin receptor substrate-2 in compensatory β-cell hyperplasia in response to high fat diet-induced insulin resistance. Diabetes Obes. Metab. 10 (Suppl. 4), 147–156 (2008).
  CAS PubMed Google Scholar
• Tourrel, C., Bailbé, D., Meile, M.-J., Kergoat, M. & Portha, B. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50, 1562–1570 (2001).
  CAS PubMed Google Scholar
• Panten, U., Schwanstecher, M. & Schwanstecher, C. Sulfonylurea receptors and mechanism of sulfonylurea action. Exp. Clin. Endocrinol. Diabetes 104, 1–9 (1996).
  CAS PubMed Google Scholar
• Hirasawa, A., Hara, T., Katsuma, S., Adachi, T. & Tsujimoto, G. Free fatty acid receptors and drug discovery. Biol. Pharm. Bull. 31, 1847–1851 (2008).
  CAS PubMed Google Scholar
• Arden,C., Baltrusch, S. & Agius, L. Glucokinase regulatory protein is associated with mitochondria in hepatocytes. FEBS Lett. 580, 2065–2070 (2006).
  CAS PubMed Google Scholar
• Miwa, I., Toyoda, Y. & Yoshie, S. in Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics. Front Diabetes. vol. 16 (eds Matschinsky, F. M. & Magnuson, M. A.) 350–359 (Karger, Basel, 2004).
  Google Scholar
• Moore, M. C., Davis, S. N., Mann, S. L. & Cherrington, A. D. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care 24, 1882–1887 (2001).
  CAS PubMed Google Scholar
• Grimsby, J. et al. Characterization of glucokinase regulatory protein deficient mice. J. Biol. Chem. 275, 7826–7831 (2000).
  CAS PubMed Google Scholar
• Munoz-Alonzo, M. J. et al. A novel cytosolic dual specificity phospatase, interacting with glucokinase, increases glucose phosphorylation rate. J. Biol. Chem. 275, 32406–32412 (2000).
  Google Scholar
• Shiraishi, A. et al. A novel glucokinase regulator in pancreatic beta-cells: precursor of propionyl-CoA carboxylase beta-subunit interacts with glucokinase and augments its activity. J. Biol. Chem. 276, 2325–2328 (2001).
  CAS PubMed Google Scholar
• Rizzo, M. A. & Piston, D. W. Regulation of beta-cell glucokinase by nitrosylation and association with nitric oxide synthase. J. Cell Biol. 161, 243–248 (2003).
  CAS PubMed PubMed Central Google Scholar
• Bjorkhauk, L., Molnes, J., Sovik, O., Njolstad, P. R. & Flatmark, T. Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin dependent cotranslational proteosomal degradation. J. Biol. Chem. 282, 22757–22764 (2007).
  Google Scholar
• Marshall, S. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci. STKE 2006, re7 (2006).
  PubMed Google Scholar
• Herman, M. A. & Kahn, B. B. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 116, 1767–1775 (2006).
  CAS PubMed PubMed Central Google Scholar
• Cuesta-Munoz, A. L. et al. The second “_de novo_” activating mutation (V452L) in a patient with developmental delay. Diabetologia 51 (Suppl. 1), 125 Abstr. 285 (2008).
• Christesen, H. B. T. et al. Activating glucokinase GCK mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation Eur. J. Endocrinol. 159, 27–34 (2008).
  CAS PubMed Google Scholar
• Wabitsch, M. et al. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy. Diabetic Med. 24, 1393–1399 (2007).
  CAS PubMed Google Scholar
• Bertram, L. S. et al. SAR, pharmacokinetics, safety, and efficacy of glucokinase activating